Literature DB >> 34568137

Prevalence and reasons behind use of injectable contraceptive among the women of reproductive age group: A cross-sectional survey in rural areas of Nadia District, West Bengal.

Anwesha Bairagya1, Gandhari Basu2, Reshmi Mondal2, Suman Kumar Roy2.   

Abstract

CONTEXT: Estimated 42 million reproductive age group women currently use injectable contraceptive, fourth most prevalent contraceptive worldwide. AIMS: To find out the prevalence, reasons and the associated factors for using injectable contraceptive among the women of reproductive age group. SETTINGS AND
DESIGN: A sub-centre-based observational, cross sectional survey was conducted among 212 reproductive age group women living in the rural areas of a district, West Bengal. METHODS AND MATERIAL: A multi-stage cluster random sampling technique was done considering villages as the cluster to get the required sample. Totally, 212 reproductive age group women were chosen from a total of 16 villages, selected by simple random sampling. Information regarding study variables was collected by direct interview of the respondents by visiting individual houses with help of a pre-designed, semi-structured proforma. Strict confidentiality and anonimousity were maintained throughout the study. STATISTICAL ANALYSIS USED: Data were analysed with SPSS 22.0 (licensed). Mean, median, proportion were used for quantitative variables whereas qualitative attributes were presented by proportion. Associations between dependent and independent variables were tested by Chi-square test.
RESULTS: The proportion of teenage marriage was unexpectedly high. More than half mothers were unwilling to have babies in future. One-third of study population used injectable contraceptive, ASHA was the main suggestion provider in choosing the method. The major reasons of use were discomfort in previous method and suggestion of service provider. Irregular menstrual problem and easy maintenance was the commonest cause of dissatisfaction and satisfaction, respectively.
CONCLUSIONS: Use of injectable contraceptive must be sincerely promoted through social marketing and the front line health workers should motivate the women to use it by providing correct information. Copyright:
© 2021 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Cross sectional survey; frontline health workers; injectable contraceptive; reproductive women; satisfaction

Year:  2021        PMID: 34568137      PMCID: PMC8415687          DOI: 10.4103/jfmpc.jfmpc_2465_20

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Family planning is important in population stabilisation as well as has got pivotal role in maternal and child health development.[1] National Family Health Survey - 3 (NFHS – 3) showed that, there is 13% unmet need for contraception and half of this need is for spacing method.[2] Worldwide injectable contraceptive came as a new set of contraceptive. There is no such birth control method which is 100% effective and safe. The side effects of most methods are not a threat to life, rather inconvenience. Injectable contraceptives are used to prevent conception along with convenience, privacy, safe and efficient protection to women. Depo medroxy progesterone acetate (DMPA) is currently used by reproductive women of 130 countries.[3] Many women consider injectable contraceptive-induced amenorrhea as beneficial and convenient one. In the formation of strategies for family planning, the perspectives of women may play a very important role in increasing client satisfaction, continuation, and also expanding method usage. Two large, open-label, phase 3 studies assessed the one year efficacy, safety, and patient satisfaction of injectable contraceptive efficacy, safety, and patient satisfaction. In both studies, no pregnancy reported and both formulations were well tolerated. The effectiveness of injectable contraceptives was found more than 99% with consistent and correct use.[4] The adverse effects are the commonest cause for discontinuation and another valid reason being the repeated injection once in three months, for which they must return to the centre. The initiative for introducing this contraceptive in national program began in 1980.[5] Globally, DMPA is considered as fourth most prevalent contraceptive. It is extensively used as a safe, effective, and acceptable measure worldwide. Approximated 42 million women of reproductive age group used this method as per choice currently across the world. In India, DMPA was approved by the Drug Controller General of India (DCGI) in 1993 for marketing purpose and in 1999, DMPA social marketing approach began.[6] The effectiveness of this contraceptive depends on first injection time, regularity, technique, and post care.[7] A prospective cohort study among immediate post-partum women in Indian setting showed unaffected lactation and non-botheration of recipients by weight gain, too.[8] A Nigeria study showed cost, informed choice and education level were the determinants of current contraceptive use.[9] There is paucity of research in investigating factors responsible either for acceptance or rejection in West Bengal. Therefore, this study was conducted to determine the prevalence, find out the reasons and the associated factors behind use of injectable contraceptive.

Subjects and Methods

An observational, descriptive epidemiological study using cross sectional survey was planned in the rural areas of Nadia District, West Bengal from January to June, 2020. Women of reproductive age group residing in the rural areas considered as the target population. The pilot study was carried out in one block of the district under study after obtaining institutional ethical clearance. IEC approval was obtained on 26-12-2019. For calculating the sample size, the prevalence of using injectable contraceptive by reproductive women (p) was assumed as 50%. The sample size calculated was 96 after considering Zα = 1.96 at 95% confidence level. The sample size became 192 after adding design effect of 2. The final sample size for the research became 212 after adding the non-response rate of 10%. Reproductive age group individuals, willing to participate and with at least one living children were included in the study. In the present study, a multi-stage cluster random sampling technique was done. [Figure 1] Villages were considered as the cluster. In the first step, two sub-divisions of the district were identified. Two blocks were randomly selected from each sub-division, and a total of four blocks were selected. From each block, four sub-centres (SC) were selected (stratified based on distance from head-quarter) which brought a total of sixteen SC that got selected. One village was randomly selected from each SC. As the sample size was 212, so for equal representation, thirteen (13) respondents were selected from each of 16 villages. If the selected village had inadequate number of women within reproductive age group, complied with inclusion criteria, the adjacent village was chosen. A pre-designed, pre-tested and semi-structured questionnaire was prepared in local vernacular for interview. The tool was first prepared in English and then it was translated into Bengali by a linguistic expert keeping semantic equivalence. Face validity of each item has been checked from previous researches in the presence of public health experts. As per their opinions, required modifications were made in the questionnaire. Information regarding variables was collected by direct interview of the respondents by visiting individual houses of the respondents along with frontline health workers. Through review of family planning related register was done to reduce recall bias. Help from ASHA and ANM were solicited to reduce the bias. Strict confidentiality and anonimousity were maintained throughout the study. Age, religion, caste, education, occupation, income, number of living children, decision maker on contraceptive use etc., were the independent variables while knowledge, practice and use of injectable contraceptives of respondents used as dependent attribute. Socio-economic status had been assessed through B. G. Prasad scale modified for the year 2018. Practice refers to use of the contraceptive methods by the women of reproductive age group. Perception refers to understanding or opinion about contraceptive methods. Knowledge refers to the correct verbal response of women of reproductive age group to the structured interview schedule. Frontline health workers refers to the Auxiliary Nurse Midwives (ANM) and Accredited Social Health Activist (ASHA) workers of the selected sub centres having working experience of at least 2 years.[10] After collection, data were entered in MS-EXCEL after coding. Mean, median, proportion were used for quantitative variables whereas qualitative attributes were presented by proportion. Chi square test was used to check associations between dependent and independent variables. All analyses were two-tailed with P less than 0.05 considered statistically significant.
Figure 1

Sampling Technique (Multistage cluster sampling technique). [SC = Sub-centre]

Sampling Technique (Multistage cluster sampling technique). [SC = Sub-centre]

Results

The present cross sectional survey was done in 212 reproductive women residing in rural areas of the study district of West Bengal. The respondents aged between 16 to 42 years. The mean (±SE) age of the respondents was 25.70 (±0.36) years. The proportion of teenage marriage was unexpectedly high (84.91%). The median family income was Rs. 8000/- per month. Socio demographic and fertility profile: Majority (95.75%) of women were aged between 15 and 35 years. Hindu and Muslims represented more or less equal (51.89% vs. 48.11%). More than half (55.18%) lived in nuclear family. Illiteracy was noted in 13 mothers, one-third completed middle education, one in every four had primary education and 35.84% had secondary or more education. Most of the respondents (91.98%) were home-makers. Regarding the educational background of husbands, 10.39% were either illiterate or they can just sign their name. More than one third (38.20%) completed primary education, 27.36% had middle level education. Nearly half (44.82%) of respondent's partners were businessman, 26.42% were engaged in agriculture. According to Prasad's SES, majority belonged to the lower middle class (68.39%). It was seen that 115 mothers two or more living children. The respondents had variance in context with age interval. More than half were unwilling to have babies in future. Institutional delivery was most common (95.75%). [Tables 1 and 2]
Table 1

Background profile of respondents (n=212)

AttributesFrequencyPercentage
Age group (years)
 16-2510951.41
 26-359444.34
 >3594.25
Age at marriage (years)
 13-1918084.91
 ≥203215.09
Education level
 Illiterate136.14
 Primary completed5325
 Middle completed7033.02
 Secondary completed4420.75
 Higher secondary and above3215.09
Employment status
 Service31.41
 Agriculture10.47
 Business136.13
 Home-maker19591.98
Social class (modified Prasad’s SES)
 Upper and upper middle31.12
 Middle5726.89
 Lower middle14568.39
 Lower73.30
Table 2

Fertility statistics of study population (n=212)

AttributesFrequencyPercentage
No. of living children
 19745.75
 2 or more11554.25
Age interval between last two children (years)
 1-34841.03
 4-64437.60
 7-92521.37
Desire for babies
 Yes9444.33
 No/No response11855.65
Feeling pressure from family members
 Yes178.02
 No/No response19591.98
Place of last delivery
 Institutional delivery20395.75
 Home delivery94.25
Background profile of respondents (n=212) Fertility statistics of study population (n=212) The proportion of use of condoms (32.07%) and injectable contraceptives (30.18%) was nearly same among the reproductive mothers. In the current study, 42.92% heard about injectable contraceptive as “Antara” and ASHA was the major (89.01%) source of information. Doctors and ANMs shared information equally. ASHA was the main suggestion provider (57.82%) in choosing injectable contraceptive followed by Government and private doctor. Regarding ideal time for having pregnancy after discontinuing injectable contraceptive, most of the respondents (64.06%) were not aware. More than half (53.13%) had correct knowledge of no bleeding after use. Majority (68.75%) of mothers had right knowledge of no risk, whereas 7.82% had wrong idea on knowledge on risk of using injectable contraceptive in cardio-vascular diseases. [Table 3] The study revealed that, more than half (51.56%) women were using this method more than one year. Among injectable contraceptive users, 41 respondents were using other contraceptives in past. The reasons of shifting were discomfort in previous method (51.22%) and suggestion of service provider (48.78%). Majority of users (90.62%) were maintaining the intervals of 3 months between last two doses.
Table 3

Prevalence of use and knowledge of injectable contraceptive

AttributesFrequencyPercentage
Use of different contraceptives (n=212)
 OCPs6832.07
 IUCDs4320.28
 Injectable contraceptives6430.18
 Condoms3717.45
Ideal interval between two doses (n=64)
 Gap of 3 months5890.63
 More than 3 months11.56
 Can’t say57.81
Ideal time for pregnancy after discontinuing injectable contraceptives (n=64)
 After 7 months2335.94
 No response4164.06
Probability of Injectable contraceptive cause bleeding problem (n=64)
 Yes2843.75
 No3453.13
 No response23.12
Contraindication of using of injectable contraceptive in breast feeding (n=64)
 Yes23.12
 No4976.56
 No response1320.32
Prevalence of use and knowledge of injectable contraceptive Twenty nine users (45.32%) were satisfied with use of injectable contraceptive. On analysing the reasons of dissatisfaction in using injectable contraceptives, irregular menstrual problem was the commonest reason (45.72%) followed by pain in lower abdomen (28.58%), weight gain (11.43%), fear due to unknown side effects (8.57%). On finding out the reasons of satisfaction, easy maintenance was the main reason (86.21%) followed by less number of side effects (13.79%). Nearly half (45.31%) of mothers were interested to continue “Antara”. Irregular menstrual cycle (65.72%) was the most common reason behind non-use followed by dizziness (20%), non-availability of husband (11.43%) and unwanted pregnancy (2.85%). [Table 4].
Table 4

Satisfaction and Reasons behind choosing injectable contraceptives

VariablesFrequencyPercentage
Satisfaction level (n=64)
 Satisfied2945.32
 Not satisfied3554.68
Reasons for dissatisfaction (n=35)
 Fear due to unknown side effects38.57
 Possible adverse effects on health12.85
 Irregular menstrual problem1645.72
 Weight gain411.43
 Dizziness12.85
 Pain in lower abdomen1028.58
 Fear due to unknown side effects38.57
Reasons for discontinuation (n=35)
 Irregular menstrual cycle2365.72
 Dizziness720
 Unwanted pregnancy12.85
 Husband out of station411.43
Satisfaction and Reasons behind choosing injectable contraceptives A good number of respondents told that they would suggest their peers in using this modern method. Majority (92.18%) was counselled on use of injectable contraceptives and ANM took major part (85.94%). Most of the users (78.13%) were counselled either twice or more, mostly during routine check-up. Four out of five users were satisfied with the counsellor. The decision to choose injectable contraceptive was taken jointly in most of the cases (96.88%). In the current study, no significant association between the variables and use of injectable contraceptive was observed. [Table 5]
Table 5

Factors associated with use of injectable contraceptive (n=212)

VariablesUse of injectable contraceptiveTest of significance

Yes (%)No (%)
Age group
 >2528 (26.92)76 (73.07)χ2=0.751, df=1, p=0.310
 >=2536 (33.33)72 (66.66)
Socio-Economic Status
 Middle and above20 (33.33)40 (66.67)χ2=0.212, df=1, p=0.530
 Upper lower and lower44 (28.95)108 (71.05)
Type of Family
 Nuclear31 (26.49)86 (73.50)χ2=0.947, df=1, p=0.193
 Joint33 (34.73)62 (65.68)
Monthly Family Income
 >8000 (Median)23 (28.04)59 (66.26)χ2=0.148, df=1, p=0.589
 <=800041 (31.53)89 (68.46)
Education level of respondents
 Up to middle level40 (29.41)96 (70.58)χ2=0.030, df=1, p=0.741
 Secondary and above24 (31.57)52 (68.42)
Place of Delivery
 Institutional delivery60 (29.55)143 (70.44)χ2=0.337, df=1, p=0.344
 Home delivery4 (44.44)5 (55.55)
Factors associated with use of injectable contraceptive (n=212)

Discussion

The current research tried to focus on finding out the prevalence and reasons behind use of injectable contraceptive among the women of reproductive age group residing in the rural areas of Nadia district. The present study had 212 women aged between 16 and 42 years with average age of 25.70 years, supported by earlier studies. The illiteracy rate among immediate post-partum women in the Jharkhand study was too high than (54% vs. 6.14%) present research reflecting better encroachment of education in rural areas of Bengal, but most of the respondents were homemaker like our one.[1112] The high-prevalence of teenage marriage in our survey might be due to socio cultural settings of the study area. One in every five women completed secondary level of education in our research. A Karnataka study carried out with 80 eligible women aged between 18 and 36 years where majority completed secondary level of education. The reason could be difference in the study setting.[8] The average age of contraceptive acceptors was found to be much higher (33.4 years) in the Nigeria study as the study respondents were using all types of contraceptives.[9] A prospective cohort study from Uganda showed that, more than half (53%) of injectable contraceptive recipients belonged to upper middle class in comparison with one third in the current study. This study also reported higher rate (77.8%) of twelve month continuation of injectable contraceptive than the present study, the reason being presence of irregular menstruation, lower abdominal pain etc.[13] Our results were similar with a study from Sub-Saharan Africa in context with stoppage of use by the adaptors within first year.[14] In the present study, nearly two-third of the users (60.52%) reported irregular menstrual problem as the cause of discontinuation that was similar with the finding reported in another study from India. This research reported irregular menstrual problem (70%), amenorrhoea (65%) as strong reasons.[8] The present study revealed that, 11.42% of users were not satisfied due to weight gain, nearly similar as claimed by study from Gujarat, India. The Gujarat study reported amenorrhea, excessive bleeding, irregular periods and weight gain as reasons for discontinuation. This study also observed that, 16% of doctors never prescribed whereas 41% were currently prescribing IC. It was also noted that, one fifth doctors found positive qualities. Inadequate counselling found to be reason of knowledge deficit regarding injectable contraceptive adverse effects that was the ultimate cause of substantial dissatisfaction in the study from Gujarat. In our study also, only 15.63% users had good knowledge and nearly one-third users had poor knowledge scores. The proportion of counselling was also too less in current study during antenatal check up at sub- centre level.[11] Another study in Indian setting claimed that, in post-partum women, lactation remained unaffected after using injectable contraceptives that was quite similar with our study, where, 76.56% of users did not feel any problem in lactation.[8] Dr. Sikha Rani in her study concluded that, use of injectable DMPA in the immediate postpartum period was an effective and safe contraceptive measure. In our study, 45.31% users agreed with this concept.[12] In the present study, among the users, 45.31% wanted to continue injectable contraceptive, whereas 60.52% users reported irregular menstrual problem, 18.42% felt dizziness. The study also stated that, despite 92.18% of the IC users were counseled, still more than half of the users (68.75%) had poor knowledge. A community based study among 457 reproductive women residing in the urban area of Mysuru showed that, the prevalence was 55.1%. Tubectomy was the commonest permanent method while male condom the most prevalent temporary contraception method. The prevalence of use of “Antara” was quite low in comparison with recent study (4.7% vs. 30.2%).[15] A cross sectional survey among 634 reproductive women of Gambia found high prevalence of injectable contraceptive usage (58.5%). Fear of adverse effects, male child preference was the main reasons behind non usage of any contraceptive by respondents. The other reasons were refusal by spouse, religious taboos, unawareness etc.[16] A study on utilization and associated factors for modern contraceptive methods done in a city of North-west Ethiopia revealed that, 41.2% practiced modern contraceptive methods, more than our study. Half of study population had well knowledge, 45.3% showed a positive attitude towards injectable contraceptives. The associated significant risk factors were for age group 20 to 29 years, early education and degree holders, women having up to six desired children, without history of previous child death, good knowledge and favourable attitude.[17] The present study has focused on prevalence and reasons for using injectable contraceptives among reproductive women and this area was not highlighted much in earlier literature. Therefore, it will help the primary care physicians to use this information as a baseline for further research. As the study was conducted in rural areas of a district of Bengal, therefore the generalisation of findings to the diversified population of India and their different living conditions could bring some bias. Quantification of some more risk factors could not be included in our study due to time and manpower constraints. The prevalence of use of injectable contraceptive was not up to satisfactory level in the present study. This modern method must be sincerely promoted through social marketing and the front line health workers can play a pivotal role. The knowledge and practice lacked. Therefore, the frontline health workers should visit the houses to promote and motivate the women of reproductive age group to use this method by providing correct information of its safety and effectiveness. They along with other service providers should give more emphasis on counselling the beneficiaries. As majority of the users did not want to continue this method in future; therefore, regular training of the front line workers, introducing performance-based incentive and supportive supervision are of utmost need. The gap in both knowledge and practice has made the researchers recommended for implementation of special awareness generation with help of community level health workers to bridge it.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Increased use of injectable contraception in sub-Saharan Africa.

Authors:  John A Ross; Alfred T Agwanda
Journal:  Afr J Reprod Health       Date:  2012-12

Review 2.  Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood.

Authors:  Suvarna Satish Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2017-07-17

3.  A Survey on Prevalence and Knowledge of Family Planning among Women of Childbearing Age in the Provincial Settings of the Gambia: A Descriptive Cross-Sectional Study.

Authors:  Amadou Barrow
Journal:  Adv Prev Med       Date:  2020-11-05

4.  Contraceptive efficacy and safety of DMPA-SC.

Authors:  J Jain; A J Jakimiuk; F R Bode; D Ross; A M Kaunitz
Journal:  Contraception       Date:  2004-10       Impact factor: 3.375

5.  Modern Contraceptive Method Utilization and Associated Factors Among Women of Reproductive Age in Gondar City, Northwest Ethiopia.

Authors:  Mohammed Oumer; Agmas Manaye; Zelalem Mengistu
Journal:  Open Access J Contracept       Date:  2020-06-24

6.  Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.

Authors:  Ellen MacLachlan; Lynn M Atuyambe; Tieba Millogo; Georges Guiella; Seydou Yaro; Simon Kasasa; Justine Bukenya; Agnes Nyabigambo; Fredrick Mubiru; Justine Tumusiime; Yentéma Onadja; Lonkila Moussa Zan; Clarisse Goeum/Sanon; Seni Kouanda; Allen Namagembe
Journal:  Contraception       Date:  2018-08-17       Impact factor: 3.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.